Timothy J. Seabrook

2.4k total citations · 1 hit paper
31 papers, 1.7k citations indexed

About

Timothy J. Seabrook is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Timothy J. Seabrook has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Physiology and 10 papers in Neurology. Recurrent topics in Timothy J. Seabrook's work include Alzheimer's disease research and treatments (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Neurogenetic and Muscular Disorders Research (9 papers). Timothy J. Seabrook is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Neurogenetic and Muscular Disorders Research (9 papers). Timothy J. Seabrook collaborates with scholars based in United States, Switzerland and United Kingdom. Timothy J. Seabrook's co-authors include Cynthia A. Lemere, Marcel Maier, Liying Jiang, Ying Peng, Michael C. Carroll, E. T. C. Spooner, Ksenija Gorni, Marta Iglesias, Eugenio Mercuri and Omar Khwaja and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and Neurology.

In The Last Decade

Timothy J. Seabrook

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risdiplam in Type 1 Spinal Muscular Atrophy

2021 260 citations Eugenio Mercuri, Ksenija Gorni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy J. Seabrook United States	19	751	635	627	299	219	31	1.7k
Masato Hosokawa Japan	26	978 1.3×	566 0.9×	715 1.1×	197 0.7×	130 0.6×	64	2.5k
Anna Erlandsson Sweden	26	805 1.1×	845 1.3×	967 1.5×	126 0.4×	179 0.8×	58	2.4k
Chadwick M. Hales United States	27	790 1.1×	279 0.4×	1.6k 2.6×	275 0.9×	105 0.5×	47	2.8k
Gerda Mitteregger Germany	22	833 1.1×	805 1.3×	1.1k 1.8×	109 0.4×	182 0.8×	32	2.2k
Satoshi Tsunoda Japan	17	648 0.9×	630 1.0×	1.0k 1.6×	64 0.2×	250 1.1×	30	2.1k
Susanna Amadio Italy	31	239 0.3×	836 1.3×	742 1.2×	221 0.7×	289 1.3×	65	2.7k
Renzo Mancuso Spain	25	956 1.3×	1.4k 2.2×	1.1k 1.7×	307 1.0×	591 2.7×	50	3.0k
Carolina Ceballos‐Diaz United States	23	992 1.3×	952 1.5×	602 1.0×	89 0.3×	270 1.2×	30	2.0k
Caty Casas Spain	26	505 0.7×	183 0.3×	1.1k 1.8×	138 0.5×	74 0.3×	51	2.4k
Jorge Marcondes de Souza Brazil	21	287 0.4×	411 0.6×	481 0.8×	157 0.5×	102 0.5×	70	1.8k

Countries citing papers authored by Timothy J. Seabrook

Since Specialization

Citations

This map shows the geographic impact of Timothy J. Seabrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Seabrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Seabrook more than expected).

Fields of papers citing papers by Timothy J. Seabrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Seabrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Seabrook. The network helps show where Timothy J. Seabrook may publish in the future.

Co-authorship network of co-authors of Timothy J. Seabrook

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Seabrook. A scholar is included among the top collaborators of Timothy J. Seabrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Seabrook. Timothy J. Seabrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Trundell, Dylan, et al.. (2020). Validity and Reliability of the 32-Item Motor Function Measure in 2- to 5-Year-Olds with Neuromuscular Disorders and 2- to 25-Year-Olds with Spinal Muscular Atrophy. Neurology and Therapy. 9(2). 575–584. 15 indexed citations

2.

Seabrook, Timothy J.. (2019). FIREFISH Part 1: 1-year event-free survival and swallowing ability in infants with Type 1 SMA. 1 indexed citations

3.

Chiriboga, Claudia A., Eugenio Mercuri, David F. Fischer, et al.. (2017). A series of case reports from JEWELFISH, an open-label study to investigate the safety, tolerability, and pharmacokinetics/ pharmacodynamics of RG7916 in adult and pediatric patients with spinal muscular atrophy who previously participated in a study with another SMN2-targeting therapy. Neuromuscular Disorders. 27. S209–S209.

4.

Quancard, Jean, Birgit Bollbuck, Philipp Janser, et al.. (2012). A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis. Chemistry & Biology. 19(9). 1142–1151. 100 indexed citations

5.

Li, Libin, et al.. (2011). The effect of FTY720 in the Theiler's virus model of multiple sclerosis. Journal of the Neurological Sciences. 308(1-2). 41–48. 12 indexed citations

6.

Seabrook, Timothy J., Amanda Littlewood-Evans, Volker Brinkmann, et al.. (2010). Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. Journal of Neuroinflammation. 7(1). 95–95. 67 indexed citations

7.

Maier, Marcel, Ying Peng, Liying Jiang, et al.. (2008). Complement C3 Deficiency Leads to Accelerated Amyloid Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice. Journal of Neuroscience. 28(25). 6333–6341. 267 indexed citations

8.

Lemere, Cynthia A., Marcel Maier, Ying Peng, Liying Jiang, & Timothy J. Seabrook. (2007). Novel Aβ Immunogens: Is Shorter Better?. Current Alzheimer Research. 4(4). 427–436. 23 indexed citations

9.

Lemere, Cynthia A., Marcel Maier, Liying Jiang, Ying Peng, & Timothy J. Seabrook. (2006). Amyloid-Beta Immunotherapy for the Prevention and Treatment of Alzheimer Disease: Lessons from Mice, Monkeys, and Humans. Rejuvenation Research. 9(1). 77–84. 55 indexed citations

10.

Maier, Marcel, Timothy J. Seabrook, Noel D. Lazo, et al.. (2006). Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response. Journal of Neuroscience. 26(18). 4717–4728. 114 indexed citations

11.

Seabrook, Timothy J., et al.. (2006). Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice. Journal of Neuroinflammation. 3(1). 14–14. 21 indexed citations

12.

Seabrook, Timothy J., Liying Jiang, Marcel Maier, & Cynthia A. Lemere. (2006). Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice. Glia. 53(7). 776–782. 181 indexed citations

13.

Seabrook, Timothy J., Liying Jiang, E. T. C. Spooner, et al.. (2006). Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice. Neurobiology of Aging. 28(6). 813–823. 48 indexed citations

14.

Maier, Marcel, Timothy J. Seabrook, & Cynthia A. Lemere. (2005). Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G). Vaccine. 23(44). 5149–5159. 36 indexed citations

15.

Maier, Marcel, Timothy J. Seabrook, & Cynthia A. Lemere. (2005). Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine. Neurodegenerative Diseases. 2(5). 267–272. 16 indexed citations

16.

Lemere, Cynthia A., Amy Beierschmitt, Marta Iglesias, et al.. (2004). Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet. American Journal Of Pathology. 165(1). 283–297. 186 indexed citations

17.

Seabrook, Timothy J., et al.. (2004). Species-specific immune response to immunization with human versus rodent Aβ peptide. Neurobiology of Aging. 25(9). 1141–1151. 21 indexed citations

18.

Seabrook, Timothy J., Bill Ristevski, Shawn G. Rhind, et al.. (2001). Epinephrine causes a reduction in lymph node cell output in sheep. Canadian Journal of Physiology and Pharmacology. 79(3). 246–252. 2 indexed citations

19.

Seabrook, Timothy J., Bill Ristevski, Shawn G. Rhind, et al.. (2001). Epinephrine causes a reduction in lymph node cell output in sheep. Canadian Journal of Physiology and Pharmacology. 79(3). 246–252. 4 indexed citations

20.

Seabrook, Timothy J., et al.. (1996). The use of the lipophilic fluorochrome CM-DiI for tracking the migration of lymphocytes. Journal of Immunological Methods. 194(2). 181–189. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact